Evidence map›Paper›PMID 39131738›Full record

ArticleFrontiers in nutrition2024

Association of serum 25-hydroxyvitamins D

Feng Chen, Yufan Gao, Yukai Wang, Ziyu Pan, Yinuo Chen, Huixiang Sheng, Qi Chen, Fan Ye

Abstract read
In one paragraph

Article in Frontiers in nutrition, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Levels of 25-hydroxyvitamin DFrontiers in neurology · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Feng Chen *The Second School of Medicine, Wenzhou Medical University, Wenzhou, China.
Yufan Gao *The Second School of Medicine, Wenzhou Medical University, Wenzhou, China.
Yukai Wang *The Second School of Medicine, Wenzhou Medical University, Wenzhou, China.
Ziyu PanThe Second School of Medicine, Wenzhou Medical University, Wenzhou, China.
Yinuo ChenThe Second School of Medicine, Wenzhou Medical University, Wenzhou, China.
Huixiang ShengThe Second School of Medicine, Wenzhou Medical University, Wenzhou, China.
Qi ChenThe School of Medicine, Zhejiang University, Hangzhou, China.
Fan YeDepartment of Otorhinolaryngology, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Hearing loss (HL) is increasingly recognized as a significant global public health issue, and research on its relationship with vitamin D levels has gained wider attention. However, the association between serum biomarkers 25-hydroxyvitamin D Methods: A sample of 3,684 individuals aged 20-69 years from the 2015-2016 National Health and Nutrition Examination (NHANES) was analyzed in this study. HL was defined as a pure tone average > 25 dB in either ear at low frequencies (500, 1,000, 2000 Hz), speech frequencies (500, 1,000, 2000, 4,000 Hz), and high frequencies (3,000, 4,000, 6,000, 8,000 Hz). Logistic regression was employed to examine the association between serum 25(OH)D Results: In the multivariate analysis, it was found that serum 25(OH)D Conclusion: Our findings suggested a positive association between serum 25(OH)D

Indexed as

25-hydroxyvitamin D225-hydroxyvitamin D3dose–responsehearing lossL-shaped association

Identifiers

PMID39131738
PMCPMC11310169

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.